ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01271283
Recruitment Status : Withdrawn
First Posted : January 6, 2011
Last Update Posted : June 4, 2015
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : August 2011